Aimee Kestranek

Chief Operating Officer at Cleveland Diagnostics

Ms. Kestranek is a seasoned biotech professional with over 20 years of experience in multiple facets of the biotech industry including R&D, Lab Operations, Sales and Marketing, Management, Clinical Studies, Quality, Product Development and Commercialization. She is a graduate of Penn State University and formally trained as an analytical chemist with extensive hands-on experience in developing and conducting high throughput physicochemical assays for the pharmaceutical industry. During her tenure with Cleveland Diagnostics she has led the commercial development of the company’s lead product, IsoPSA™ including final product configuration, clinical study management and data analysis, tech transfer to contract manufacturing and FDA submission. She has implemented comprehensive companywide Safety Program and Quality System.

As the Vice President of Analytical Services at Analiza, Inc., Ms. Kestranek has been responsible for managing the creation and expansion of Analiza’s physicochemical properties testing capabilities and providing technical leadership to its staff over the last 10 years. In addition to her analytical skill set, she has successfully established client relationships with top-tier pharmaceutical organizations in a highly complex, evolving business climate.


Org chart


Teams


Offices

This person is not in any offices


Cleveland Diagnostics

1 followers

Cleveland Diagnostics is developing a breakthrough technology to discover a new class of diagnostics tests with high sensitivity and specificity for many cancers – early on, when cancer is still curable.


Industries

Employees

11-50

Links